Hemoptysis caused by a left subclavian pseudoaneurysm: endovascular solution for a challenging case

Bernal, Lucas Ribé; Portero, J.L.; Vila, M. Planas; Ruiz, Diego; Reparaz, L.

doi:10.1258/vasc.2011.cr0266

Cited by 4 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In cases of ruptured MAAs, endovascular repair may be an appropriate alternative, as a definitive treatment or until debridement and a final treatment may be performed. There is still ongoing controversy in the literature regarding the endovascular option as a main therapy or as an alternative [23,30,37,39,43].…”

Section: Endovascularmentioning

confidence: 99%

Mycotic Aortic Aneurysms

Bernal¹,

Requejo²,

Ribes³

et al. 2020

Aortic Aneurysm and Aortic Dissection

View full text Add to dashboard Cite

Various studies have evaluated the possibilities of surgical repair of mycotic aortic aneurysms (MAAs). Open surgical repair has usually been accepted as the gold standard treatment of MAAs. The main concern is that it carries a significant mortality risk, varying from 20 to 40% in different studies, and a 5-year survival rate of 30-50%. The largest study of open surgical treatment of mycotic aortic aneurysms (MAA) was published in 2018, and consisted of 187 patients of whom open repairs were performed in 107 patients (57%). Most of the endovascular series conclude that endovascular treatment of MAA is feasible and an acceptable alternative treatment to open repair. Although endovascular repair might be a durable option for some patients, late infection-associated complications frequently occur and are often lethal. An overall analysis of this rare pathology, its different diagnostic modalities, treatment options, and prognosis are presented and discussed in this chapter.

show abstract